ASO Author Reflections: Which HIPEC Regimens Should be Used in Patients with Epithelial Ovarian Cancer? In the Clinic and in Randomized Trials

Ann Surg Oncol. 2023 Dec;30(13):8166-8167. doi: 10.1245/s10434-023-13981-8. Epub 2023 Jul 21.

Authors

Aditi Bhatt¹, Olivier Glehen², Naoual Bakrin², Donal Brennan³, Willemien Van Driel⁴

Affiliations

¹ Deparment of Surgical Oncology, KD Hospital, Ahmedabad, India. aditimodi31@gmail.com.
² Deparment of Surgical Oncology, Centre Hospitalier, Lyon-sud, Lyon, France.
³ UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
⁴ Deparment of Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

PMID: 37477748
DOI: 10.1245/s10434-023-13981-8

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Ovarian Epithelial
Cytoreduction Surgical Procedures
Female
Humans
Hyperthermia, Induced*
Hyperthermic Intraperitoneal Chemotherapy
Ovarian Neoplasms*
Randomized Controlled Trials as Topic